A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
Clinical trial NCT07321873 · RECRUITING
Trial details
- NCT number
- NCT07321873
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-15
- Primary completion
- 2027-06-28
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.